Acetyl-CoA acyltransferase 2 as a metabolic modulator: Unraveling its impact on hepatic lipid dynamics in chicken embryos
- PMID: 40738480
- DOI: 10.1016/j.bbalip.2025.159674
Acetyl-CoA acyltransferase 2 as a metabolic modulator: Unraveling its impact on hepatic lipid dynamics in chicken embryos
Abstract
Despite the established role of acetyl-CoA acyltransferase 2 (ACAA2) in hepatic lipid homeostasis in mammals, its function in regulating hepatic lipid metabolism during the embryonic stage of chickens remains unexplored. This study aimed to explore the regulatory role of ACAA2 in hepatic lipid metabolism and investigate its molecular mechanisms in chicken embryos. A recombinant ACAA2-shRNA plasmid was successfully constructed for targeted suppression of ACAA2 expression. Knockdown of ACAA2 significantly increased triglyceride content, promoted lipid droplet accumulation, and upregulated lipogenesis-related gene expression in chicken embryos. The knockdown of ACAA2 significantly suppressed both mRNA and protein expression of peroxisome proliferator-activated receptor α (PPARα) and carnitine palmitoyl transferase 1 (CPT1), while conversely upregulating sterol regulatory element binding protein-1c (SREBP-1c) mRNA and protein expression. Notably, these metabolic alterations caused by ACAA2 knockdown were markedly reversed by the activation of PPARα in primary chicken embryonic hepatocytes, suggesting functional crosstalk between the ACAA2 and PPARα signaling pathways. These results indicate that fat accumulation action of the knockdown of ACAA2 was due to enhancing SREBP-1c expression and reducing PPARα expression. In present study, ACAA2 was identified as a critical modulator of embryonic lipid metabolism, offering a target for interventions to reduce embryonic mortality or metabolic diseases in poultry.
Keywords: Acetyl-CoA acyltransferase 2; Chicken embryo; Hepatic lipid; Hepatocyte; Metabolism.
Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
[Mechanisms of puerarin-mediated lipid modulation to enhance glucose-lowering effects via hepatic ChREBP/PPARα/PPARγ in vitro].Zhongguo Zhong Yao Za Zhi. 2025 Jul;50(14):3951-3961. doi: 10.19540/j.cnki.cjcmm.20250305.401. Zhongguo Zhong Yao Za Zhi. 2025. PMID: 40904082 Chinese.
-
Salidroside protects bovine hepatocytes against fatty acid-induced lipid accumulation and inflammation by activating AMPK/SIRT1 pathway.J Dairy Sci. 2025 Sep;108(9):10136-10150. doi: 10.3168/jds.2024-26083. Epub 2025 Jul 9. J Dairy Sci. 2025. PMID: 40645487
-
PPARα is one of the key targets for dendrobine to improve hepatic steatosis in NAFLD.J Ethnopharmacol. 2024 Apr 6;323:117684. doi: 10.1016/j.jep.2023.117684. Epub 2024 Jan 1. J Ethnopharmacol. 2024. PMID: 38171466
-
The metabolic and molecular mechanisms linking fructose consumption to lipogenesis and metabolic disorders.Clin Nutr ESPEN. 2025 Jun 25;69:63-68. doi: 10.1016/j.clnesp.2025.06.042. Online ahead of print. Clin Nutr ESPEN. 2025. PMID: 40578484 Review.
-
Lipid metabolism-related genes in gastric cancer: Exploring oncogenic pathways.World J Gastrointest Oncol. 2025 Aug 15;17(8):106842. doi: 10.4251/wjgo.v17.i8.106842. World J Gastrointest Oncol. 2025. PMID: 40837774 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous